Stay updated on S65487 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S65487 Combo with Azacitidine in AML Clinical Trial page
- Check6 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the study history.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new version entry, Revision: v3.4.2, was added, while the funding notice and the earlier Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and updated the page revision to v3.4.1, while removing the previous revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedThe page now includes a 'Show glossary' option and retains color-coded change highlights (green for additions, red for deletions). The revision text updated from v3.3.4 to v3.4.0 and the 'No FEAR Act Data' line was removed.SummaryDifference1.0%

- Check84 days agoChange DetectedA new Revision: v3.3.3 entry was added to the site history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check113 days agoChange DetectedThe Record History shows an added revision entry for v3.3.2 and removal of v3.2.0, reflecting a site version update rather than changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to S65487 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.